Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: A cross-sectional study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Armah, Kaku A ^a   Quinn, Emily K ^b   Cheng, Debbie M ^b,c   Tracy, Russell P ^d   Baker, Jason V ^e   Samet, Jeffrey H ^b,c   Freiberg, Matthew S ^a,f  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Comorbidity; HCV; HIV; Inflammation; Liver

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C; INTERLEUKIN 10; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; RNA ANALYSIS; SUBSTANCE ABUSE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ALCOHOL DRINKING; BIOLOGICAL MARKERS; COHORT STUDIES; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 84883183682     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-399     Document Type: Article

References (40)

1. Freiberg MS, Chang CC, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Goetz MB, Butt AA, Rodriguez Barradas MC, et al. The risk of incident coronary heart disease among veterans with and without HIV and Hepatitis C. Circ Cardiovasc Qual Outcomes 2011, 4(4):425-432. 10.1161/CIRCOUTCOMES.110.957415, 3159506, 21712519.
2. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med 2010, 11(7):462-468.
3. Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009, 49(2):225-232. 10.1086/599371, 3077953, 19508169.
4. Freiberg MS, Cheng DM, Kraemer KL, Saitz R, Kuller LH, Samet JH. The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS 2007, 21(2):193-197. 10.1097/QAD.0b013e3280118a0d, 1805683, 17197810.
5. Justice AC, Freiberg MS, Tracy R, Kuller L, Tate JP, Goetz MB, Fiellin DA, Vanasse GJ, Butt AA, Rodriguez-Barradas MC, et al. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. Clin Infect Dis 2012, 54(7):984-994. 10.1093/cid/cir989, 3297653, 22337823.
6. Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011, 203(6):780-790. 10.1093/infdis/jiq118, 3071127, 21252259.
7. Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, Natarajan V, Rehm C, Hadigan C, Sereti I. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS 2010, 24(10):1509-1517. 10.1097/QAD.0b013e32833ad914, 2884071, 20505494.
8. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5(10):e203. 10.1371/journal.pmed.0050203, 2570418, 18942885.
9. Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr 2007, 46(2):194-199. 10.1097/QAI.0b013e318142aabb, 2247363, 17667330.
10. Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses 2004, 20(2):151-155. 10.1089/088922204773004860, 15018702.
11. Smith KL, Horton NJ, Saitz R, Samet JH. The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend 2006, 82(3):231-237. 10.1016/j.drugalcdep.2005.09.012, 16256278.
12. Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, Goetz M, Tracy R, Oursler KK, Rimland D, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis 2012, 55(1):126-136. 10.1093/cid/cis406, 3493182, 22534147.
13. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101(15):1767-1772. 10.1161/01.CIR.101.15.1767, 10769275.
14. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342(12):836-843. 10.1056/NEJM200003233421202, 10733371.
15. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996, 144(6):537-547.
16. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394(6696):894-897. 10.1038/29788, 9732872.
17. Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, Skoutelis A, Goetz MB, Phillips AN. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 2009, 200(6):973-983. 10.1086/605447, 2892757, 19678756.
18. Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010, 201(12):1788-1795. 10.1086/652749, 2872049, 20446848.
19. Hurlimann J, Thorbecke GJ, Hochwald GM. The liver as the site of C-reactive protein formation. J Exp Med 1966, 123(2):365-378. 10.1084/jem.123.2.365, 2138142, 4379352.
20. Morrow JF, Stearman RS, Peltzman CG, Potter DA. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 1981, 78(8):4718-4722. 10.1073/pnas.78.8.4718, 320234, 6946420.
21. Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8(5):446-454. 10.1097/00042560-199504120-00003, 7697440.
22. Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol 2000, 38(2):575-577. 86151, 10655348.
23. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, SS M, Torriani FJ, Dieterich DT, Thomas DL, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43(6):1317-1325. 10.1002/hep.21178, 16729309.
24. Sobell MB, Sobell LC, Klajner F, Pavan D, Basian E. The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research. Addict Behav 1986, 11(2):149-161. 10.1016/0306-4603(86)90040-7, 3739800.
25. U.S. Department Of Health & Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism Helping Patients Who Drink Too Much. A clinician's guide. Updated 2005 Edition. [http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/guide.pdf], U.S. Department Of Health & Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism.
26. Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH. Interleukin-6 Is Associated with Noninvasive Markers of Liver Fibrosis in HIV-Infected Patients with Alcohol Problems. AIDS Res Hum Retroviruses 2013, 29(8):1110-1116. 10.1089/aid.2012.0348, 23601055.
27. Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT. Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res 2007, 27(4):263-269. 10.1089/jir.2006.0147, 17477814.
28. El-Hage N, Dever SM, Fitting S, Ahmed T, Hauser KF. HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses. J Virol 2011, 85(22):11601-11614. 10.1128/JVI.05239-11, 3209310, 21900165.
29. Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ. Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology 2004, 40(1):125-132. 10.1002/hep.20258, 15239095.
30. Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair JB, Chapman S, Taylor LE, Paranhos-Baccala G, Chung RT. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol 2006, 78(2):202-207. 10.1002/jmv.20528, 16372286.
31. Floris-Moore M, Howard AA, Lo Y, Schoenbaum EE, Arnsten JH, Klein RS. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS 2007, 21(7):479-491. 10.1089/apc.2006.0150, 2423809, 17651029.
32. Reingold J, Wanke C, Kotler D, Lewis C, Tracy R, Heymsfield S, Tien P, Bacchetti P, Scherzer R, Grunfeld C, et al. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study. J Acquir Immune Defic Syndr 2008, 48(2):142-148. 10.1097/QAI.0b013e3181685727, 2561207, 18344877.
33. Barrett L, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K, Grant M. Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunol 2008, 9:28. 10.1186/1471-2172-9-28, 2443791, 18554409.
34. Cribier B, Schmitt C, Rey D, Lang JM, Kirn A, Stoll-Keller F. Production of cytokines in patients infected by hepatitis C virus. J Med Virol 1998, 55(2):89-91. 10.1002/(SICI)1096-9071(199806)55:2<89::AID-JMV1>3.0.CO;2-J, 9598926.
35. Lapinski TW, Parfieniuk A, Rogalska-Plonska M, Czajkowska J, Flisiak R. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int 2009, 29(8):1158-1161. 10.1111/j.1478-3231.2009.02052.x, 19602133.
36. Gonzalez SA, Zhang C, Fiel MI, Chung S, Zhang L, Jacobson IM, Talal AH. Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection. J Viral Hepat 2008, 15(5):331-338. 10.1111/j.1365-2893.2007.00949.x, 18179452.
37. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006, 12(11):1301-1309. 10.1038/nm1492, 2535582, 17041596.
38. Baker J, Ayenew W, Quick H, Hullsiek KH, Tracy R, Henry K, Duprez D, Neaton JD. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis 2010, 201(2):285-292. 10.1086/649560, 2798007, 19954384.
39. Nunez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol 2006, 44(1 Suppl):S132-139.
40. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511. 10.1161/01.CIR.0000052939.59093.45, 12551878.